Press release
Circulating Tumor Cells (CTC) Market Growth Size Share Analysis 2022-2029
Circulating Tumor Cells (CTC) Market Growth Size Share Analysis 2022-2029||DataM Intelligence
Browse Full Report at: https://www.datamintelligence.com/research-report/circulating-tumor-cells-market
Our research report gives wide perceptions of the latest trends and development prospects of the market analysis, detailed segmentation analysis, volume, size, share, growth drives, and opportunities in the market. In-depth regional and country-level illustration of the competitive landscape depends on several phases and status of clinical trials over the prominent economies of the globe, and also report contains a number of major companies profiled in the relevant market.
Market Drivers:
The circulating tumor cells (CTC) market is driven by factors such as rising technological advancements, an increasing geriatric population, and improvements in CTC diagnostic and enrichment technology are expected to drive the CTC market. The market's growth can also be attributed to the rising number of research and development, clinical trials, and conferences to increase awareness about the technology.
Moreover, the availability of technologically advanced devices by key players is also expected to play a vital role in the market's growth. Rising government funding and increasing healthcare expenditure to treat chronic diseases will boost market growth. Another driving factor for the circulating tumor cells (CTC) market is the high adoption rate of CTC technology for diagnostic and guiding prognosis. Thus, increasing awareness about novel circulatory tumour cell technology among patients and hospitals will provide market players with better opportunities in the future. Various novel product launches and research studies contribute to the market's growth. For instance, in Nov 2021, Menarini Silicon Biosystems, liquid biopsy technologies company, announced its commercial launch of CELLSEARCH, a laboratory-developed test for counting the circulating multiple myeloma cells (CMMC) from the blood. This assay provides early detection of disease and its progression in patients at risk.
Download Sample Report at: https://www.datamintelligence.com/download-sample/circulating-tumor-cells-market
Market Segmentation:
By Technology:
• CTC Detection Technology
• CTC Enrichment Technology
By Application:
• EMT Biomarkers Development
• Tumorigenesis Research
• Cancer Stem Cell
• Others
Geographical Classification:
• North America
• Latin America
• Europe
• Asia Pacific
• Middle East
• Africa
Major Companies Listed:
QIAGEN N.V., Bio-Techne Corporation, Biocept Inc., Thermo Fisher Scientific, LungLife AI, Inc., Menarini Silicon Biosystems, Miltenyi Biotec, Precision Medicine Group, Fluxion Biosciences Inc., BioFluidica and more.
Trending Topics:
Neuroendocrine Tumor Treatment: https://www.datamintelligence.com/research-report/neuroendocrine-tumor-treatment-market
Tumor Ablation Market: https://www.datamintelligence.com/research-report/tumor-ablation-market
miRNA Tools and Services Market: https://www.datamintelligence.com/research-report/mirna-tools-and-services-market
DataM Intelligence 4market Research LLP
Ground floor, DSL Abacus IT Park,
Industrial Development Area, Uppal,
Hyderabad, Telangana 500039.
DataM Intelligence was incorporated in the early weeks of 2017 as a Market Research and Consulting firm with just two people on board. Within a span of less than a year, we have secured more than 100 unique customers from established organizations all over the world.
We monitor and analyse the market by dissecting various market influencers, competitive intensity, innovations, trends, and emerging products. This aids us in providing a detailed scenario of the present and future of the market.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Circulating Tumor Cells (CTC) Market Growth Size Share Analysis 2022-2029 here
News-ID: 2838628 • Views: …
More Releases from DataM Intelligence
U.S. Radiopharmaceuticals Market to Reach USD 2.36 Billion by 2033, Growing at 6 …
The United States radiopharmaceuticals market was valued at USD 2.21 billion in 2024 and is projected to reach USD 2.36 billion by 2033, exhibiting a CAGR of 6.3% during the forecast period, according to DataM Intelligence. The market expansion is primarily fueled by the growing prevalence of chronic diseases such as cancer and cardiovascular disorders, advancements in diagnostic imaging, and regulatory support for nuclear medicine infrastructure. Radiopharmaceuticals play a pivotal…
U.S. Food Flavors Market to Reach USD 6.1 Billion by 2033, Registering 5.2% CAGR …
The U.S. flavors market was valued at USD 3,887.7 million in 2024 and is projected to reach USD 6,108.4 million by 2033, growing at a CAGR of 5.2% during 2025-2033, according to DataM Intelligence. The market's growth is driven by surging demand for processed foods, global flavor innovation, and increasing consumer preference for natural, clean-label, and wellness-oriented products. Flavors continue to play a vital role in enhancing the sensory experience…
Europe Feed Premix Market to Reach USD 7.31 Billion by 2030, Growing at a 4.32% …
The Europe Feed Premix Market is estimated to grow from USD 5.92 billion in 2025 to USD 7.31 billion by 2030, registering a CAGR of 4.32% during the forecast period, according to DataM Intelligence. The market's growth is driven by increasing demand for nutrient-rich animal feed formulations, expanding livestock production, and a rising preference for high-quality, antibiotic-free animal products. Feed premixes-comprising essential vitamins, minerals, amino acids, and other additives-are vital…
North America Feed Phytogenics Market to Reach USD 500.6 Million by 2030, Growin …
The North America Feed Phytogenics Market is projected to grow from USD 383.10 million in 2025 to USD 500.60 million by 2030, at a CAGR of 5.5% during the forecast period, according to DataM Intelligence. The market is witnessing robust growth due to rising demand for high-quality animal-derived products and increasing regulatory restrictions on antibiotics in livestock production. As a result, plant-based feed solutions have gained widespread adoption for improving…
More Releases for CTC
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
A new market study report by The Insight Partners on the Circulating Tumor Cell (CTC) Market has been released with reliable information and accurate forecasts for a better understanding of the current and future market scenarios. The report offers an in-depth analysis of the global market, including qualitative and quantitative insights, historical data, and estimated projections about the market size and share in the forecast period.
Get PDF Sample…
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
Circulating Tumor Cell (CTC) Market business research report assesses the current as well as upcoming performance of the market, also brand-new trends in the market. It provides product overview and highlights of product and application segments of the market including price, revenue, sales, sales growth rate, and market share by product. The market statistics within the report is displayed in a statistical format to offer a better understanding upon the…
Circulating Tumor Cells (CTC) Market - Industry Trends and Forecast
The Circulating Tumor Cells (CTC) market is expanding rapidly, driven by increasing interest in liquid biopsy technologies, advancements in cancer diagnostics, and the growing prevalence of cancer globally. Circulating Tumor Cells are cancer cells that break away from the primary tumor and circulate in the bloodstream, potentially leading to the development of secondary tumors (metastasis). CTCs offer a non-invasive method to monitor cancer progression, assess treatment efficacy, and detect early…
Circulating Tumor Cell (CTC) Market Future Prediction Report By 2028
The Circulating Tumor Cell (CTC) Market business intelligence report by "The Insight Partners" entails detailed information regarding the dynamics affecting market valuation over the analysis period. It also covers the competitive landscape, market scope, and market segmentation.
Get PDF Sample Report + All Related Table and Graphs @: https://www.theinsightpartners.com/sample/TIPRE00026639/?utm_source=OpenPR&utm_medium=10852
The report has been curated after observing and studying various factors that determine regional growth such as economic, environmental, social, technological,…
Circulating Tumor Cells (CTC) Market by Technology (CTC Analysis, CTC Enrichment …
The Circulating Tumor Cells (CTC) Market is expected to gain considerable market share by 2025, while registering itself at a significant compound annual growth rate (CAGR) during the forecast period. Circulating tumor cells are essentially helpful in deciding the status of disease progression rate and projection of treatment required for the elimination of the tumor. Further advancement of different tumor markers that can be useful alongside diagnostics to monitor or…
Circulating Tumor Cells (CTC) Market Demands with Major Newest Innovations: CTC …
Circulating Tumor Cells (CTC) Market By Technology (CTC Analysis, CTC Enrichment and CTC Detection), By Application (EMT biomarkers development, Tumorigenesis research, Cancer stem cell research and others) - Global Industry Analysis & Forecast to 2025.
Competitive Insights:
The major players in the market are Biocept, ScreenCell, Biofluidica Inc, Fluxion Biosciences, Advanced Cell Diagnostics, Greiner Bio-One, Aviva Biosciences, Epic Sciences, Janssen Diagnostics, Clearbridge BioMedics Pte Ltd and CellTraffix Inc. The major players in…
